Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1984 1
1986 1
1989 1
1990 1
1993 1
1994 2
1996 4
1997 2
1998 3
1999 4
2000 5
2001 10
2002 7
2003 16
2004 39
2005 42
2006 90
2007 139
2008 260
2009 138
2010 44
2011 48
2012 57
2013 47
2014 48
2015 50
2016 41
2017 33
2018 27
2019 26
2020 24
2021 31
2022 19
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19194995

1,066 results

Results by year

Filters applied: . Clear all
Page 1
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR; Atomoxetine ADHD/SUD Study Group. Wilens TE, et al. Drug Alcohol Depend. 2008 Jul 1;96(1-2):145-54. doi: 10.1016/j.drugalcdep.2008.02.009. Epub 2008 Apr 9. Drug Alcohol Depend. 2008. PMID: 18403134 Clinical Trial.
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
Atomoxetine ADHD and Comorbid MDD Study Group; Bangs ME, Emslie GJ, Spencer TJ, Ramsey JL, Carlson C, Bartky EJ, Busner J, Duesenberg DA, Harshawat P, Kaplan SL, Quintana H, Allen AJ, Sumner CR. Atomoxetine ADHD and Comorbid MDD Study Group, et al. J Child Adolesc Psychopharmacol. 2007 Aug;17(4):407-20. doi: 10.1089/cap.2007.0066. J Child Adolesc Psychopharmacol. 2007. PMID: 17822337 Clinical Trial.
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A; LYCY Study Group. Dell'Agnello G, et al. Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. doi: 10.1016/j.euroneuro.2009.07.008. Epub 2009 Aug 28. Eur Neuropsychopharmacol. 2009. PMID: 19716683 Clinical Trial.
A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder.
Manor I, Ben-Hayun R, Aharon-Peretz J, Salomy D, Weizman A, Daniely Y, Megiddo D, Newcorn JH, Biederman J, Adler LA. Manor I, et al. J Clin Psychiatry. 2012 Dec;73(12):1517-23. doi: 10.4088/JCP.12m07767. J Clin Psychiatry. 2012. PMID: 23290324 Free article. Clinical Trial.
1,066 results